Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19)

NCT04760743 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 (Healthy Volunteers)

Interventions

BIOLOGICAL: NBP2001 adjuvanted with alum (RBD 30μg/dose)
BIOLOGICAL: NBP2001 adjuvanted with alum (RBD 50μg/dose)
OTHER: Normal Saline

Sponsor

SK Bioscience Co., Ltd.